This website is intended for US healthcare professionals only.
Contact Us
Contact BioCryst
Submit an Inquiry
Request a Grant or Sponsorship
Expanded-Access Program
Search Medical Information
Clinical Trials
Congresses
Publications
Disease State Information & Resources
Hereditary Angioedema (HAE)
Netherton Syndrome (NS)
Diabetic Macular Edema (DME)
Complement-Mediated Diseases
Clinical Trials
Congresses
Publications
Disease State Information & Resources
Hereditary Angioedema (HAE)
Netherton Syndrome (NS)
Diabetic Macular Edema (DME)
Complement-Mediated Diseases
Contact Us
Contact BioCryst
Submit an Inquiry
Request a Grant or Sponsorship
Expanded-Access Program
Search Medical Information
Hereditary angioedema in children: Review and practical perspective for clinical management
biocryst
December 10, 2024
Androgen transition and management of hereditary angioedema long-term prophylaxis in real life: a single-center case series
biocryst
July 9, 2024
Hereditary Angioedema (HAE)
Hereditary angioedema outcomes in US patients switched from injectable long-term prophylactic medication to oral berotralstat
biocryst
April 1, 2024
Clinical Experience with Berotralstat in Patients with Hereditary Angioedema with Normal C1-Esterase Inhibitor: A Commented Case Series
biocryst
February 23, 2024
Once-daily oral berotralstat for long-term prophylaxis of hereditary angioedema: The open-label extension of the APeX-2 randomized trial
biocryst
December 18, 2023
Assessment of HAE prophylaxis transition from androgen therapy to berotralstat: A subset analysis of the APeX-S trial
biocryst
November 6, 2023
Long-Term Safety and Effectiveness of Berotralstat for Hereditary Angioedema: The Open-Label APeX-S Study
biocryst
June 18, 2021
